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Objective: To investigate associations of biochemical markers of joint metabolism and inﬂammation with
minimum joint space width (JSW) and osteophyte area (OP area) of knees showing no or doubtful
radiographic osteoarthritis (OA) and to investigate whether these differed between painful and non-
painful knees.
Design: Serum (s-) and urinary (u-) levels of the cartilage markers uCTX-II, sCOMP, sPIIANP, and sCS846,
bone markers uCTX-I, uNTX-I, sPINP, and sOC, synovial markers sPIIINP and sHA, and inﬂammation
markers hsCRP and erythrocyte sedimentation rate (ESR) were assessed in subjects from CHECK (Cohort
Hip and Cohort Knee) demonstrating Kellgren and Lawrence grade 1 OA on knee radiographs. Mini-
mum JSW and OP area of these knees were quantiﬁed in detail using Knee Images Digital Analysis (KIDA).
Results: uCTX-II levels showed negative associations with minimum JSW and positive associations with
OP area. sCOMP and sHA levels showed positive associations with OP area, but not with minimum JSW.
uCTX-I and uNTX-I levels showed negative associations with minimum JSW and OP area. Associations of
biochemical marker levels with minimum JSW were similar between painful and non-painful knees,
associations of uCTX-II, sCOMP, and sHA with OP area were only observed in painful knees.
Conclusions: In these subjects with no or doubtful radiographic knee OA, uCTX-II might not only reﬂect
articular cartilage degradation but also endochondral ossiﬁcation in osteophytes. Furthermore, sCOMP
and sHA relate to osteophytes, maybe because synovitis drives osteophyte development. High bone
turnover may aggravate articular cartilage loss. Metabolic activity in osteophytes and synovial tissue, but
not in articular cartilage may be related to knee pain.
© 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Knee osteoarthritis (OA) is among the most disabling diseases in
the developed world and its societal burden is only expected toW.E. Van Spil, Department of
dical Center Utrecht, PO Box
1-88-7557357; Fax: 31-30-
(W.E. Van Spil), s.c.nair@
l (M.B. Kinds), Pj.Emans@
(W.K.H.A. Hilberdink), p.m.j.
cutrecht.nl (F.P.J.G. Lafeber).
ternational. Published by Elsevier Lincrease further due to aging of the population, higher life expec-
tancy, and the ongoing obesity epidemic1. Many approaches are
followed to unravel the pathogenesis of OA and identify therapeutic
targets. Biochemical markers have been proposed to be tools that
could help along the challenging road to this point2. They can inform
about the molecular events underlying the structural joint changes
that characterize knee OA. Also, they can suggest what metabolic
processes may be involved in the development of knee pain. In
earlier studies, especially biochemical markers of cartilage degra-
dation and synthesis, synovial activity (synovitis), and inﬂammation
were associated with knee pain in OA3e6. Yet, how the presence of
knee pain inﬂuenced associations of biochemical markers with in-
dividual radiographic OA features was not investigated.td. All rights reserved.
Fig. 1. Screenshot of KIDA. Small and larger circles are positioned in relation to a
framework demarcating the knee joint. The framework and circles are positioned
automatically, but their positions can be adjusted manually. JSW is assessed between
the small circles aligning the bone-cartilage interface (dotted lines). Osteophyte area is
determined outside the larger circles positioned at the corners of the lateral and
medial femur and tibia. Bone density is assessed within the small circles, by normal-
ization to an aluminum step wedge (rectangle) included on all radiographs. For details
see references 10 and 12.
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markers of joint metabolism and inﬂammation were assessed in
subjects from CHECK (Cohort Hip and Cohort Knee), with painful
and/or non-painful knees, with either no or doubtful radiographic
OA (Kellgren and Lawrence, K&L, grade 0 or 1). Of these knees,
minimum joint space width (JSW) and osteophyte area (OP area)
were quantiﬁed in detail using semi-automated Knee Images Dig-
ital Analysis (KIDA). Then, associations of biochemical marker levels
with minimum JSW and OP area were assessed to investigate what
metabolic processes underlie these radiographic features. Finally,
associations of biochemical marker levels and radiographic features
were compared between painful and non-painful knees to deter-
mine whether this metabolic activity in articular cartilage and
osteophytes might be relevant for having knee pain.
Method
Cohort characteristics
The current study was performed with baseline data from
CHECK, a cohort of subjects age 45e65 years, with pain and/or
stiffness of one or both knee(s) and/or hip(s), that had never or not
longer than 6 months ago visited a general physician for these
complaints for the ﬁrst time7. Pain was classiﬁed as either present
or absent according to the history of the patient that was obtained
by an experienced rheumatologist. Subjects with any other path-
ological condition (e.g., other rheumatic disease, previous joint
replacement) that could explain these symptoms were excluded.
Biochemical marker assessment
Biochemical marker levels were assessed in serum and second
morning void urine samples, collected in a non-fasted state, be-
tween 8 and 12 AM. Marker levels were assessed by enzyme-
linked immunosorbent assay or radioactive immunoassay, ac-
cording to manufacturer instructions, as was described previ-
ously8. Intra-plate, inter-plate, and between-day coefﬁcients of
variation (standard deviation/mean*100%) were as follows: C-
terminal telopeptide of collagen type II (CTX-II; Urine Cartilaps
EIA, Immunodiagnostic systems Ltd., Boldon, UK): 10.0%, 9.3%,
and 12.4%. Cartilage oligomeric matrix protein (COMP; AnaMar
Med AB, G€oteborg, Sweden): 5.0%, 4.0%, and 4.2%. N-terminal
propeptide of procollagen type IIA (PIIANP; Millipore Corp, Bill-
erica, MA, US): 15.8%, 7.0%, and 15.7%. Chondroitin sulfate 846
(CS846; IBEX, Montreal, Canada): 21.5%, 16.9%, and 15.3%. C-ter-
minal telopeptide of collagen type I (CTX-I, Urine CrossLaps EIA,
Immunodiagnostic systems Ltd., Boldon, UK): 9.7%, 6.1%, and
2.7%. N-terminal telopeptide of collagen type I (NTX-I, OSTEO-
MARK NTx Urine, Wampole laboratories, Princeton, US): 14.9%,
6.6%, and 10.7%. N-terminal propeptide of procollagen type I
(PINP, UniQ, Orion Diagnostica, Espoo, Finland): 4.4%, 4.5%, and
6.2%. Osteocalcin (OC, N-MID Osteocalcin ELISA, Immunodiag-
nostic systems Ltd., Boldon, UK): 3.4%, 4.1%, and 4.3%. Hyaluronic
acid (HA; Corgenix Inc, Westminster, CO, US): 15.1%, 13.0%, and
17.3%. N-terminal propeptide of procollagen type III (PIIINP; UniQ,
Orion Diagnostica, Espoo, Finland): 5.4%, 3.2%, and 7.2%. Urinary
biomarker levels were adjusted for urinary creatinine concen-
trations (automated kinetic assay, UniCel® DxC 800 Synchron®
Clinical System, Beckman Coulter). Serum levels of high-
sensitivity C-reactive protein (hsCRP) were assessed by an auto-
mated nephelometric assay (BN™ II analyzer, Siemens, routine
clinical chemistry laboratory, University Medical Center Utrecht,
Utrecht, The Netherlands). Erythrocyte sedimentation rate (ESR)
was assessed according to clinical practice in each of the ten
participating medical centers.Acquisition of radiographic data
Radiographs of tibiofemoral knee joints were made in a post-
eroanterior view, weight-bearing, semiﬂexed (7e10), according to
BucklandeWright9. Joint space narrowing (JSN) and osteophytosis
were considered cardinal features of early-stage knee OA and were
quantiﬁed on these radiographs using KIDA10 (Fig. 1). Minimum
JSW (in millimeters, mm) and OP area at the lateral and medial
femur and tibia (in mm2) were determined as was reported
before11. Subchondral sclerosis was not selected as outcome of
early-stage OA but was included as a potential confounder of as-
sociations of biochemical marker levels with minimum JSWand OP
area. Subchondral bone density (subchondral BD), as a measure of
sclerosis, was determined at the lateral and medial femur and tibia
compartments (in mm aluminum equivalence, mmAl) by normal-
izing the grayscales of these compartments to grayscales of an
aluminum step wedge that was included on all radiographs, as was
explained before12, and was averaged for all compartments. All
measurements were performed by one observer, with intraclass
correlation coefﬁcients as determined by random reanalysis of 108
radiographs after a few months between 0.730 and 0.990.
Since other joints than the tibiofemoral knee joint would also
contribute to systemic levels of biochemical markers and OA in this
one joint may be a risk factor for OA in other joints, associations of
systemic biochemical marker levels with radiographic parameters
of the tibiofemoral knee joint needed to be tested (adjusted) for
potential confounding by concurrent OA features in other joints.
Radiographs were available for the patellofemoral knee joints and
hip joints.
Radiographs of patellofemoral knee joints were made in a
standing mediolateral and in a skyline (inferior superior) view,
W.E. Van Spil et al. / Osteoarthritis and Cartilage 23 (2015) 48e5650both in 30 ﬂexion. JSN and osteophytes were scored on a 0e3
scale and sclerosis on a 0e1 scale, according to Burnett et al.13.
When scores differed between mediolateral and the skyline views
of the patellofemoral knee joint, the maximum score was used in
our analyses.
Hip radiographs were made in an anteroposterior (AP) view of
the pelvis, with hips in 15 internal rotation, and in a faux proﬁl
(FP) view of each hip, all weight-bearing. JSN and osteophytes
were scored on a 0e3 scale and sclerosis on a 0e1 scale,Fig. 2. Flow diagram of the inclusion procedure of 1002 CHECK subjects (2004 knees) for th
distributed variables, as median (25e75% percentiles) for skewed variables, and as proport
space width; JSN, joint space narrowing; K&L, Kellgren and Lawrence; OP, osteophyte/osteaccording to Altman et al.14. JSN was scored at the superior and
medial joint space on the AP radiographs and at the superior and
posterior joint space on the FP radiographs. Scores were summed
for each view. When these sum scores differed between views,
the highest sum score was used in our analyses. Osteophytes
were scored at the superior and inferior acetabulum and femur
on the AP radiographs and scores were summed. Subchondral
sclerosis was scored at the femoral compartment on the AP
radiographs.e current study. Data ranges are presented as mean ± standard deviation for normally
ion (%) per category for discrete variables. BD, bone density; min JSW, minimum joint
ophytosis; patellofem, patellofemoral.
Table I
Demographic parameters and biochemical marker levels for those subjects for
whom radiographic data were and were not complete. To be included in the current
study, radiographic OA features of the tibiofemoral and patellofemoral knee joints
and hip joints were required. A ﬂow diagram of the inclusion process is demon-
strated in Fig. 2. Data ranges are presented as mean ± standard deviation for nor-
mally distributed variables, as median (25e75% percentiles) for skewed variables,
and as proportion (%) per category for discrete variables. Comparison of variables
between subjects with and without complete radiographic data was performed
using independent-samples T test for continuous variables and Chi-square test for
categorical variables. Statistically signiﬁcant associations are in bold.
608 subjects with
one or two knees for
which radiographic
were complete
394 subjects with
no knees for which
radiographic data
were complete
P for
comparison
Age 55.9 ± 5.3 55.9 ± 5.1 years 0.933
BMI 25.2 (23.1e27.9) 25.9 (23.8e28.7) kg/m2 0.007
Gender 22/78 19/81 % male/
female
0.296
uCTX-II 186 (129e282) 204 (138e285) ng/mmol 0.024
sCOMP 8.5 (7.2e10.0) 8.3 (7.2e9.8) U/l 0.405
sPIIANP 1380 (1072e1778) 1380 (1122e1799) ng/ml 0.573
sCS846 67.6 (53.7e87.1) 72.4 (57.5e89.1) ng/ml 0.431
uCTX-I 145 (98e219) 158 (105e240) mg/mmol 0.192
uNTX-I 37.2 (26.9e50.1) 38.0 (28.8e51.3) nM
BCE/mmol
0.348
sPINP 41.7 (32.4e55.0) 42.7 (32.7e56.2) ng/ml 0.315
sOC 12.9 (10.5e16.6) 13.2 (10.5e16.6) ng/ml 0.848
sHA 25.7 (16.2e42.7) 28.8 (18.6e44.7) ng/ml 0.044
sPIIINP 4.1 (3.5e4.9) 4.1 (3.5e4.9) ng/ml 0.899
hsCRP 1.3 (0.6e3.0) 1.6 (0.8e3.5) mg/l 0.008
ESR 7.9 (5.0e12.9) 7.3 (5.0e12.9) mm/hr 0.442
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KIDA parameters of the both knees that are assessed within one
subject cannot be considered independent11. Therefore, associa-
tions of biochemical marker levels with minimum JSW and OP area
of the tibiofemoral knee joints in one subject were investigated by
two-level linear mixed-effects models, the ﬁrst level being the
knees and the second level being the subjects, using a random
intercept and ﬁxed effects. In each of the models, either minimum
JSW or OP area were used as outcome, while factors in each of the
models were the biochemical marker of interest, radiographic pa-
rameters, demographic variables, and/or knee pain. Linear models
assume that the relationship between the outcome and the ﬁxed
effects can be modeled through a linear function, that the variance
is not a function of the mean, and that residuals of the model are
normally distributed. Each of these assumptions was fulﬁlled in our
linear mixed-effects models.
Associations of biochemical marker levels with minimum JSW
and OP area were adjusted for potential confounding in three
consecutive steps. In the ﬁrst step, associations of biochemical
marker levels with one of the KIDA parameters (e.g., minimum
JSW) were adjusted for the other KIDA parameters of the tibiofe-
moral knee joint (e.g., OP area and subchondral BD). In the second
step, associations between biochemical marker levels and KIDA
parameters were adjusted for concurrent radiographic OA features
of patellofemoral knee joints and hip joints. Finally, in the third
step, associations were also adjusted for demographic variables
(i.e., age, gender, and body mass index (BMI)). In these analyses,
BMI and biochemical marker levels were logarithmically trans-
formed and the square root of the OP area was used to obtain
normally distributed residuals for the regression models. Con-
founding factors were selected in accordance with common use in
biomarker literature and theoretical backgrounds.
Not all CHECK subjects were included based on knee pain and
knee pain was not always bilateral, therefore not all knees were
painful. To identify whether metabolic activity in articular cartilage
and osteophytes was related to having knee pain, associations of
biochemical marker levels with minimum JSW and OP area were
evaluated for interaction with presence of knee pain. Statistically
signiﬁcant interaction indicates that the association of that marker
with the outcome (i.e., minimum JSW or OP area) differs between
painful and non-painful knees. Therefore, whenever interaction
was statistically signiﬁcant, the association of that marker with that
KIDA parameter was determined for painful and non-painful knees
separately.
To facilitate direct comparison between regression coefﬁcients
of variables and models, coefﬁcients are expressed as standardized
betas (stand betas). Standardized betas represent the number of
standard deviations that the outcome will change as a result of one
standard deviation change in the predictor. Therefore, they are
independent of the units of measurement of the variables and can
vary between 1 and 1.
All statistical analyses were performed using SAS, version 9.1.
Statistical signiﬁcance was deﬁned as P values <0.05, except for
interaction terms that were considered statistically signiﬁcant at P
values <0.100.
Results
Subject and knee characteristics
Fig. 2 shows for how many of the 1002 subjects (2004 knees)
radiographic data were available for the tibiofemoral knee joint
(KIDA) and for the patellofemoral knee joints and hip joints (Alt-
man classiﬁcation). Ultimately, for 594 subjects (1041 knees) allthese radiographic data as well as demographic parameters were
available. Of these knees, 661 knees were scored K&L grade 0 and
380 knees were scored K&L grade 1. K&L grade 1 knees expectedly
showed a smaller minimum JSW, a larger OP area, and a higher
subchondral BD. Interestingly, K&L grade 1 knees were also asso-
ciated with more severe OA features of the patellofemoral knee
joints and hip joints.
Table I demonstrates that subjects with and without complete
radiographic data did not show clinically relevant, although
sometimes statistically signiﬁcant, differences for any of the de-
mographics or biochemical markers.
For a maximum number of 12 samples per biochemical marker,
marker levels were outside standard curves. Non-linear dilution
effects hampered assessment of marker levels in diluted samples.
To prevent bias from excluding these samples, marker levels in
these samples were arbitrarily set at 80% of the minimum level or
120% of the maximum level that was assessed in samples inside
standard curves8. Results did not differ essentially between ana-
lyses with and without these samples.
Minimum JSW
The putative cartilage degradation marker uCTX-II showed a
negative association with minimum JSW (stand beta ¼ 0.107,
P ¼ 0.004, adjusted for concurrent knee and hip OA features) that
disappeared after adjustment for demographic variables, partic-
ularly BMI (data not shown). The bone degradation markers
uCTX-I and uNTX-I showed negative associations with minimum
JSW (stand beta ¼ 0.128, P ¼ 0.001, and stand beta ¼ 0.130,
P < 0.001, respectively, adjusted for concurrent knee and hip OA
features) that remained for uCTX-I and disappeared for uNTX-I
after adjustment for demographic variables (stand
beta ¼ 0.085, P ¼ 0.043, stand beta ¼ 0.076, P ¼ 0.064,
respectively), particularly gender (data not shown). The synovial
markers sHA and sPIIINP showed positive associations with
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only after adjustment for demographics (stand beta ¼ 0.100,
P ¼ 0.022), particularly age (data not shown), and was
strengthened for sPIIINP after adjustment for demographics
(stand beta ¼ 0.122, P ¼ 0.002). The inﬂammation marker ESR
showed a negative association with minimum JSW (stand
beta ¼ 0.091, P ¼ 0.017, adjusted for concurrent knee and hip OA
features) that disappeared after adjustment for demographic
variables, gender in particular. The negative association of hsCRP
with minimum JSW (stand beta ¼ 0.074, P ¼ 0.038, adjusted for
OP area and subchondral BD) already disappeared after adjust-
ment for concurrent patellofemoral and hip OA features.
None of the biochemical markers showed statistically signiﬁcant
interaction with presence of knee pain in their associations with
minimum JSW (Table II, most right column).
OP area
First, all knees were analyzed, irrespective of presence of pain
(Table III). uCTX-II and sCOMP, both putative cartilage degrada-
tion markers, showed positive associations with OP area (stand
beta ¼ 0.062, P ¼ 0.044, and stand beta ¼ 0.092, P ¼ 0.005,Table II
Associations of biochemical marker levels with minimum JSW of the knees as measured
biochemical marker levels with minimum JSW were consecutively adjusted for OP area
features of the patellofemoral knee joints and of the hip joints (scored according to Burn
Standardized betas, 95% conﬁdence intervals (95% CI), and P values are displayed. P value
association with minimum JSW are shown in the most right column. Statistically signiﬁ
deviations that the outcome will change as a result of one standard deviation change in
width; OP area, osteophyte area; rad OA, radiographic osteoarthritis
Independent Dependent variable: Min JSW
Adjusted for
OP area, subch BD knee þRad OA features patellofemora
knee joint and hip
uCTX-II 0.115 0.107
95% CI 0.182 to 0.048 0.180 to 0.035
P value <0.001 0.004
sCOMP 0.045 0.042
95% CI 0.025 to 0.114 0.035 to 0.119
P value 0.207 0.287
sPIIANP 0.037 0.029
95% CI 0.107 to 0.032 0.106 to 0.048
P value 0.293 0.461
sCS846 0.024 0.036
95% CI 0.093 to 0.0451 0.114 to 0.042
P value 0.493 0.365
uCTX-I 0.120 0.128
95% CI 0.190 to 0.051 0.205 to 0.050
P value <0.001 0.001
uNTX-I 0.131 0.130
95% CI 0.199 to 0.062 0.206 to 0.055
P value <0.001 <0.001
sPINP 0.012 0.009
95% CI 0.081 to 0.057 0.085 to 0.067
P value 0.724 0.821
sOC 0.014 0.018
95% CI 0.054 to 0.081 0.058 to 0.094
P value 0.691 0.645
sHA 0.041 0.055
95% CI 0.028 to 0.110 0.023 to 0.133
P value 0.246 0.167
sPIIINP 0.076 0.102
95% CI 0.007 to 0.146 0.027 to 0.177
P value 0.032 0.008
ESR 0.073 0.091
95% CI 0.142 to 0.005 0.166 to 0.016
P value 0.036 0.017
hsCRP 0.074 0.057
95% CI 0.144 to 0.004 0.134 to 0.020
P value 0.038 0.145respectively, adjusted for concurrent knee and hip OA features).
The bone degradation markers uCTX-I and uNTX-I showed
negative associations with OP area (stand beta ¼ 0.072,
P ¼ 0.029, and stand beta ¼ 0.077, P ¼ 0.017, respectively,
adjusted for concurrent knee and hip OA features). The synovial
marker sHA showed a positive association with OP area (stand
beta ¼ 0.083, P ¼ 0.011, adjusted for concurrent knee and hip OA
features). All these associations disappeared after adjustment for
demographic variables, mostly BMI (data not shown). In addition,
the inﬂammation marker ESR showed a negative association with
OP area only after adjustment for concurrent knee and hip OA
features and demographic variables (stand beta ¼ 0.076,
P ¼ 0.025).
Associations of OP area with uCTX-II, sCOMP, and sHA showed
statistically signiﬁcant interaction with the presence of pain
(P  0.02) and were therefore also analyzed in painful and non-
painful knees separately. It appeared that the positive associa-
tions of uCTX-II, sCOMP, and sHAwith OP area were only present in
painful knees (stand beta¼ 0.100, P¼ 0.007, and stand beta¼ 0.140,
P < 0.001, and stand beta ¼ 0.116, P ¼ 0.004, respectively, adjusted
for concurrent knee and hip OA features), but not in non-painful
knees (Table IV).by KIDA and analyzed using mixed-effects models. From left to right, associations of
and subchondral BD of the knees (both quantiﬁed using KIDA), for concurrent OA
ett and Altman, respectively), and for demographic variables (age, gender, and BMI).
s for the interaction of the biochemical markers with presence of knee pain in their
cant associations are in bold. Standardized betas represent the number of standard
the predictor. Subch BD, subchondral bone density; min JSW, minimum joint space
l þDemographic variables Interaction with presence of knee pain
0.046
0.123 to 0.030
0.238 0.255
0.043
0.037 to 0.123
0.294 0.144
0.009
0.068 to 0.087
0.811 0.683
0.034
0.112 to 0.043
0.388 0.157
0.085
0.167 to 0.003
0.043 0.291
0.076
0.157 to 0.004
0.064 0.921
0.022
0.055 to 0.098
0.576 0.948
0.059
0.019 to 0.136
0.139 0.803
0.100
0.014 to 0.185
0.022 0.178
0.122
0.045 to 0.198
0.002 0.830
0.025
0.107 to 0.056
0.539 0.374
0.017
0.101 to 0.066
0.681 0.466
Table III
Associations of biochemical marker levels with OP area of the knees as measured by KIDA and analyzed using mixed-effects models. From left to right, associations of
biochemical marker levels with OP area were consecutively adjusted for minimum JSW and subchondral BD of the knees (both quantiﬁed using KIDA), for concurrent OA
features of the patellofemoral knee joints and of the hip joints (scored according to Burnett and Altman, respectively), and for demographic variables (age, gender, and BMI).
Standardized betas, 95% conﬁdence intervals (95% CI), and P values are displayed. P values for the interaction of the biochemical markers with presence of knee pain in their
associationwith OP area are shown in the most right column. Statistically signiﬁcant associations are in bold. Standardized betas represent the number of standard deviations
that the outcomewill change as a result of one standard deviation change in the predictor. Subch BD, subchondral bone density; min JSW, minimum joint spacewidth; OP area,
osteophyte area; rad OA, radiographic osteoarthritis
Independent Dependent variable: OP area
Adjusted for
Min JSW, subch BD knee þRad OA features patellofemoral
knee joint and hip
þDemographic variables Interaction with presence of knee pain
uCTX-II 0.086 0.062 0.052
95% CI 0.024 to 0.148 0.002 to 0.123 0.011 to 0.115
P value 0.007 0.044 0.108 0.015
sCOMP 0.111 0.092 0.047
95% CI 0.047 to 0.174 0.028 to 0.155 0.019 to 0.114
P value 0.001 0.005 0.164 0.016
sPIIANP 0.033 0.045 0.057
95% CI 0.097 to 0.031 0.109 to 0.019 0.122 to 0.007
P value 0.310 0.171 0.080 0.475
sCS846 0.042 0.029 0.012
95% CI 0.022 to 0.105 0.035 to 0.094 0.052 to 0.077
P value 0.198 0.369 0.712 0.120
uCTX-I 0.074 0.072 0.047
95% CI 0.138 to 0.009 0.137 to 0.007 0.115 to 0.022
P value 0.025 0.029 0.181 0.254
uNTX-I 0.071 0.077 0.063
95% CI 0.134 to 0.007 0.140 to 0.014 0.130 to 0.005
P value 0.030 0.017 0.068 0.564
sPINP 0.033 0.029 0.022
95% CI 0.096 to 0.0305 0.093 to 0.034 0.086 to 0.041
P value 0.308 0.364 0.491 0.162
sOC 0.024 0.019 0.004
95% CI 0.086 to 0.038 0.082 to 0.045 0.069 to 0.061
P value 0.451 0.565 0.907 0.262
sHA 0.137 0.083 0.036
95% CI 0.075 to 0.199 0.019 to 0.147 0.035 to 0.107
P value <0.001 0.011 0.323 0.020
sPIIINP 0.054 0.036 0.013
95% CI 0.011 to 0.118 0.027 to 0.098 0.078 to 0.052
P value 0.101 0.261 0.695 0.175
ESR 0.036 0.057 0.076
95% CI 0.099 to 0.027 0.119 to 0.004 0.142 to 0.010
P value 0.267 0.069 0.025 0.474
hsCRP 0.024 0.006 0.065
95% CI 0.040 to 0.089 0.070 to 0.058 0.134 to 0.005
P value 0.458 0.846 0.067 0.442
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The current study shows multiple associations of systemic
biochemical marker levels with radiographic minimum JSWand OP
area that were quantiﬁed in detail in knees with no or doubtful
radiographic OA according to the K&L classiﬁcation system. The
putative cartilage degradation marker uCTX-II showed a negative
association with minimum JSW and a positive association with OP
area. The putative cartilage degradation marker sCOMP showed a
positive associationwith OP area but no associationwith minimum
JSW. The bone degradation markers uCTX-I and uNTX-I showed
positive associations with minimum JSW and negative associations
with OP area. The synovial markers sHA and sPIIINP showed posi-
tive associations with minimum JSW and the inﬂammation
markers ESR and hsCRP showed negative associations with mini-
mum JSW. Associations of biochemical marker levels with mini-
mum JSW were independent of knee pain, whereas associations of
uCTX-II, sCOMP, and sHA with OP area were only observed in
painful knees. These data inform about possible metabolic pro-
cesses underlying the radiographic features of OA and whether
more active metabolism in articular cartilage and osteophytes may
be related to knee pain.CTX-II is proposed to be a marker of articular cartilage degra-
dation. In our study, uCTX-II levels were indeed negatively associ-
ated with minimum JSW, which is in accordance with literature
data6,15e22. uCTX-II levels were also positively associated with OP
area, which again is in accordance with studies showing positive
associations of uCTX-II levels with knee and/or hip osteo-
phytes18,20,23,24. CTX-II release from osteophytes may originate
from the osteoclastic resorption of calciﬁed cartilage that is part of
the endochondral ossiﬁcation in osteophytes25e28. Associations of
uCTX-II levels with minimum JSW did not differ between painful
and non-painful knees, while associations of uCTX-II levels with OP
area did. Apparently, CTX-II is released from articular cartilage
irrespective of knee pain, but CTX-II is released from osteophytes in
painful knees and not in non-painful knees (i.e., not to such an
extent that this can be detected in urine and related to OP area).
This indicates that metabolic activity in osteophytes may be
involved in having knee pain, but metabolic activity in articular
cartilage may not29.
COMP is most frequently interpreted as a marker of cartilage
degradation30,31, but is present in other tissues as well32e34. In our
study, both sCOMP and sHA did not show associations with mini-
mum JSW, but showed positive associations with OP area. Both HA
Table IV
Associations of biochemical marker levels with OP area of the knees as measured by
KIDA, analyzed in painful (65%) and non-painful (35%) knees separately. From left to
right, associations of biochemical marker levels with OP area were consecutively
adjusted for minimum JSW and subchondral BD of the knee (both quantiﬁed using
KIDA), for concurrent OA features of the patellofemoral knee joints and of the hip
joints (scored according to Burnett and Altman, respectively), and for demographic
variables (age, gender, and BMI). Standardized betas, 95% conﬁdence intervals (95%
CI), and P values are displayed. Statistically signiﬁcant associations are in bold.
Standardized betas represent the number of standard deviations that the outcome
will change as a result of one standard deviation change in the predictor. BD, bone
density; min JSW, minimum joint space width; OA, osteoarthritis; OP, osteophyte
area; rad OA, radiographic osteoarthritis
Independent Dependent variable: OP area
Adjusted for
Min JSW,
subch BD
knee
þRad OA features
patellofemoral
knee joint
and hip
þDemographic
variables
Knee
pain
uCTX-II 0.136 0.100 0.084
95% CI 0.062 to 0.209 0.028 to 0.172 0.009 to 0.159
P value <0.001 0.007 0.029
No knee
pain
uCTX-II 0.017 0.012 0.032
95% CI 0.088 to 0.122 0.083 to 0.107 0.070 to 0.136
P value 0.744 0.801 0.537
Knee
pain
sCOMP 0.141 0.140 0.108
95% CI 0.062 to 0.220 0.061 to 0.219 0.024 to 0.192
P value <0.001 <0.001 0.012
No knee
pain
sCOMP 0.071 0.038 0.014
95% CI 0.025 to 0.168 0.052 to 0.127 0.104 to 0.076
P value 0.145 0.404 0.758
Knee pain sHA 0.170 0.116 0.069
95% CI 0.094 to 0.245 0.039 to 0.193 0.019 to 0.155
P value <0.001 0.004 0.122
No knee
pain
sHA 0.110 0.040 0.005
95% CI 0.014 to 0.209 0.058 to 0.137 0.100 to 0.111
P value 0.029 0.424 0.918
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synovial tissue matrix33,37. Therefore, the positive associations of
sHA and sCOMP levels with osteophytes may be considered in
support of osteophyte development being driven by synovitis26,38
as is syndesmophyte development in ankylosing spondylitis.
Moreover, the positive associations of sHA and sCOMPwith OP area
were present in painful knees only, which suggests that metaboli-
cally active (inﬂamed?) synovial tissue, maybe (also) through
osteophyte formation, is involved in having knee pain39. Alterna-
tively, sCOMP may have originated from articular cartilage but its
translocation from synovial ﬂuid to blood may have increased in
presence of synovitis40.
ESR and hsCRP levels showed negative associations with mini-
mum JSW, that only persisted for ESR after adjustment for con-
current patellofemoral and hip OA features. Assuming that ESR and
hsCRP reﬂect synovitis in the current context, this conﬁrms the
notion that synovitis plays a role in cartilage damage41. This hy-
pothesis contradicts the negative association of ESR with OP area,
since also osteophyte growth may be driven by synovitis. This
negative association appears counter-intuitive and may be a coin-
cidental ﬁnding in multiple testing or be confounded by other,
extra-articular, processes, (e.g., systemic inﬂammation unrelated to
synovitis).
The positive associations of sHA and sPIIINP levels with mini-
mum JSW were counter-intuitive as well, since it is unlikely that
processes characterized by increased HA loss and/or production or
by ﬁbrosis42e44 would protect against articular cartilage degrada-
tion. This unexpected ﬁnding may be attributable to confounding.
First of all, both markers have limited tissue speciﬁcity42e45. Sec-
ond, synovitis may drive articular cartilage degradation as well asincrease clearance of biochemical markers from synovial ﬂuid to
blood. Finally, these associations may have been confounded by a
positive association between JSW and total joint size.
In our study, high uCTX-I and uNTX-I levels were associated
with more severe JSN (smaller minimum JSW) and less osteo-
phytosis (smaller OP area). Assuming that elevated levels of these
bone markers represent high rates of subchondral bone turnover,
these ﬁndings would corroborate ﬁndings in animal models of
early-stage OA. In these models, increased subchondral bone
turnover preceded actual sclerosis and was related to a decrease
in JSW46. Alternatively, biochemical markers released from sub-
chondral bone turnover might be overwhelmed by biochemical
markers released from systemic (skeletal) bone turnover.
Assuming that these bone markers represent systemic bone
metabolism, and high rates of bone turnover attenuate bone
mineralization, this would mean that low systemic bone mineral
density is detrimental for articular cartilage thickness but pro-
tects against osteophytosis. This would be in apparent accordance
with studies showing that high systemic bone mineral density
decreases the risk of progression of radiographic knee OA (mainly
by reducing JSN)47, but may be associated with an increased risk
of incident radiographic knee OA (mainly by an increased risk of
osteophyte development)47e49.
All associations between tibiofemoral knee OA features and
systemic biochemical marker levels were adjusted stepwise for
potentially confounding factors (patellofemoral knee OA features,
hip OA features, and demographics). Among the tested con-
founders, particularly patellofemoral OA features and de-
mographics appeared to be associated with tibiofemoral OA
features (data not shown). However, demographics showed
stronger associations with systemic biochemical marker levels than
patellofemoral OA features did. Accordingly, particularly (adjust-
ment for) demographics appeared to affect associations between
tibiofemoral KIDA parameters and systemic biochemical marker
levels.
Obvious strengths of the current study are its large size, the
large number and broad variety of biochemical markers that were
simultaneously assessed, and the detailed quantiﬁcation of radio-
graphic knee parameters using KIDA. But, of course, this study has
limitations also. First, serial biochemical marker data would have
been preferable over the current baseline data but were not avail-
able. Second, not all KIDA data were available for all (knees of)
CHECK subjects due to the high radiographic quality needed for
quantitative evaluation of radiographs by KIDA. Since differences
between subjects with and without complete data were minor, this
will not have affected internal and external validity of the study.
Third, in the current study K&L grade 0 and 1 knees were analyzed
together, although these may in fact represent different entities50.
However, sample size and effect sizes in this early-stage OA pop-
ulationwere too small to allow separate analysis of K&L grade 0 and
1 knees. Fourth, MRImight have been preferable over the current X-
ray imaging for assessing the early-stage OA parameters in our
study population. Nevertheless, X-ray imaging is still the most
widely used imaging modality in clinical practice and interpreta-
tion of MRI ﬁndings is not always straight forward either. Another
limitation of our method for assessing JSW is that total joint size
may have confounded JSW. Measures for total joint size were not
available. Reassuring in this respect, however, is the positive asso-
ciation between our continuous measure of minimum JSW and the
JSN grade according to the widely used categorical Altman classi-
ﬁcation system (data not shown). Finally, knee pain was classiﬁed
as either present or absent according to the history of the patient.
Use of a standardized instrument might have been better, although
pain will always remain a subjective parameter and deﬁning cut-
offs for presence or absence of pain arbitrary. Moreover, currently
W.E. Van Spil et al. / Osteoarthritis and Cartilage 23 (2015) 48e56 55available standardized instruments are not developed for the very
early-stage OA subjects that were part of the current study.
In conclusion, serum and urinary levels of markers of joint
metabolism and inﬂammation showed multiple associations with
minimum JSW and OP area when they were analyzed in detail in
knees with no or doubtful OA according to the K&L classiﬁcation
system. In this context, urinary CTX-II levels may not only represent
articular cartilage degradation, but also endochondral ossiﬁcation
in osteophytes. Similarly, COMP may originate from synovial tissue
rather than from articular cartilage. Furthermore, high turnover of,
either subchondral or systemic, bone may aggravate JSN. Finally,
metabolic activity in synovial tissue and osteophytes but not
articular cartilage were suggested to be involved in having knee
pain. Synovitis may cause pain directly as well as indirectly through
driving osteophyte development.
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